These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 9668535

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The pharmacological manipulation of fetal haemoglobin: trials using hydroxyurea and recombinant human erythropoietin.
    el-Hazmi MA, al-Momen A, Warsy AS, Kandaswamy S, Huraib S, Harakati M, al-Mohareb F.
    Acta Haematol; 1995; 93(2-4):57-61. PubMed ID: 7543719
    [Abstract] [Full Text] [Related]

  • 4. Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules.
    Chaidos A, Makis A, Hatzimichael E, Tsiara S, Gouva M, Tzouvara E, Bourantas KL.
    Acta Haematol; 2004; 111(4):189-95. PubMed ID: 15153710
    [Abstract] [Full Text] [Related]

  • 5. Influence of thalassemia on the response to recombinant human erythropoietin in dialysis patients.
    Cheng IK, Lu HB, Wei DC, Cheng SW, Chan CY, Lee FC.
    Am J Nephrol; 1993; 13(2):142-8. PubMed ID: 8342581
    [Abstract] [Full Text] [Related]

  • 6. Single and combination drug therapy for fetal hemoglobin augmentation in hemoglobin E-beta 0-thalassemia: Considerations for treatment.
    Singer ST, Kuypers FA, Olivieri NF, Weatherall DJ, Mignacca R, Coates TD, Davies S, Sweeters N, Vichinsky EP.
    Ann N Y Acad Sci; 2005; 1054():250-6. PubMed ID: 16339672
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic superiority and safety of combined hydroxyurea with recombinant human erythropoietin over hydroxyurea in young β-thalassemia intermedia patients.
    Elalfy MS, Adly AA, Ismail EA, Elhenawy YI, Elghamry IR.
    Eur J Haematol; 2013 Dec; 91(6):522-33. PubMed ID: 23927461
    [Abstract] [Full Text] [Related]

  • 8. Serum erythropoietin and erythropoiesis in high- and low-fetal hemoglobin beta-thalassemia intermedia patients.
    Galanello R, Barella S, Turco MP, Giagu N, Cao A, Dore F, Liberato NL, Guarnone R, Barosi G.
    Blood; 1994 Jan 15; 83(2):561-5. PubMed ID: 7506955
    [Abstract] [Full Text] [Related]

  • 9. Use of recombinant erythropoietin in thalassemic patients on dialysis.
    Lai KN, Wong KC, Li PK, Lui SF.
    Am J Kidney Dis; 1992 Mar 15; 19(3):239-45. PubMed ID: 1553968
    [Abstract] [Full Text] [Related]

  • 10. On the use of hydroxyurea/erythropoietin combination therapy for sickle cell disease.
    el-Hazmi MA, al-Momen A, Kandaswamy S, Huraib S, Harakati M, al-Mohareb F, Warsy AS.
    Acta Haematol; 1995 Mar 15; 94(3):128-34. PubMed ID: 7502628
    [Abstract] [Full Text] [Related]

  • 11. Improvement of erythropoiesis in beta-thalassemic mice by continuous erythropoietin delivery from muscle.
    Bohl D, Bosch A, Cardona A, Salvetti A, Heard JM.
    Blood; 2000 May 01; 95(9):2793-8. PubMed ID: 10779423
    [Abstract] [Full Text] [Related]

  • 12. Sustained increase in haemoglobin and RBC following long-term administration of recombinant human erythropoietin to patients with homozygous beta-thalassaemia.
    Rachmilewitz EA, Aker M, Perry D, Dover G.
    Br J Haematol; 1995 Jun 01; 90(2):341-5. PubMed ID: 7794754
    [Abstract] [Full Text] [Related]

  • 13. Hemoglobin switching protocols in thalassemia. Experience with sodium phenylbutyrate and hydroxyurea.
    Dover GJ.
    Ann N Y Acad Sci; 1998 Jun 30; 850():80-6. PubMed ID: 9668530
    [Abstract] [Full Text] [Related]

  • 14. Combination therapy of erythropoietin, hydroxyurea, and clotrimazole in a beta thalassemic mouse: a model for human therapy.
    de Franceschi L, Rouyer-Fessard P, Alper SL, Jouault H, Brugnara C, Beuzard Y.
    Blood; 1996 Feb 01; 87(3):1188-95. PubMed ID: 8562946
    [Abstract] [Full Text] [Related]

  • 15. Hydroxyurea therapy in thalassemia.
    Loukopoulos D, Voskaridou E, Stamoulakatou A, Papassotiriou Y, Kalotychou V, Loutradi A, Cozma G, Tsiarta H, Pavlides N.
    Ann N Y Acad Sci; 1998 Jun 30; 850():120-8. PubMed ID: 9668534
    [Abstract] [Full Text] [Related]

  • 16. Induction of fetal globin in beta-thalassemia: Cellular obstacles and molecular progress.
    Perrine SP, Castaneda SA, Boosalis MS, White GL, Jones BM, Bohacek R.
    Ann N Y Acad Sci; 2005 Jun 30; 1054():257-65. PubMed ID: 16339673
    [Abstract] [Full Text] [Related]

  • 17. Flow cytometric analysis of hydroxyurea effects on fetal hemoglobin production in cultures of beta-thalassemia erythroid precursors.
    Amoyal I, Goldfarb A, Fibach E.
    Hemoglobin; 2003 May 30; 27(2):77-87. PubMed ID: 12779269
    [Abstract] [Full Text] [Related]

  • 18. Effect of Tumor Necrosis Factor-Alpha on Erythropoietin and Erythropoietin Receptor-Induced Erythroid Progenitor Cell Proliferation in β-Thalassemia/Hemoglobin E Patients.
    Tanyong DI, Panichob P, Kheansaard W, Fucharoen S.
    Turk J Haematol; 2015 Dec 30; 32(4):304-10. PubMed ID: 26376749
    [Abstract] [Full Text] [Related]

  • 19. Recombinant human erythropoietin in the treatment of multiple myeloma-associated anemia.
    Mittelman M, Zeidman A, Fradin Z, Magazanik A, Lewinski UH, Cohen A.
    Acta Haematol; 1997 Dec 30; 98(4):204-10. PubMed ID: 9401498
    [Abstract] [Full Text] [Related]

  • 20. Recombinant human erythropoietin therapy in a transfusion-dependent beta-thalassemia major patient.
    Makis AC, Chaliasos N, Hatzimichael EC, Bourantas KL.
    Ann Hematol; 2001 Aug 30; 80(8):492-5. PubMed ID: 11563599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.